Open AccessCardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy
Author(s) -
Mouhamed Nashawi,
Mahmoud S. Ahmed,
Toka Amin,
Mujahed Abualfoul,
Robert Chilton
Publication year - 2021
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v13.i12.676
Subject(s) - medicine , endocrinology , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes , cotransporter , sodium , chemistry , organic chemistry